Jones Financial Companies
HRMY icon

Jones Financial Companies’s Harmony Biosciences HRMY Stock Holding History

Jones Financial Companies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Hold
291
– – ﹤0.01% 3772
2026
Q1 		$7.72K Buy
291
+272
+1,432% +$8.92K ﹤0.01% 3672
2025
Q4 		$711 Sell
19
-150
-89% -$4.93K ﹤0.01% 4096
2025
Q3 		$4.65K Hold
169
– – ﹤0.01% 3386
2025
Q2 		$5.41K Buy
169
+19
+13% +$611 ﹤0.01% 3111
2025
Q1 		$4.98K Hold
150
– – ﹤0.01% 2961
2024
Q4 		$5.16K Buy
+150
New +$5.15K ﹤0.01% 2746

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's HRMY Position: Q2 2026 in Review

Jones Financial Companies held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 291 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.

Jones Financial Companies first reported a position in HRMY in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jones Financial Companies held 291 shares of Harmony Biosciences worth $10.3K as of Q2 2026.
  • Jones Financial Companies left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3772 holding.
  • Jones Financial Companies first reported a position in Harmony Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.